by October Gallery
(Reuters) – The U.S. Food and Drug Administration has approved Alexion Pharmaceuticals Inc’s blood disorder drug Ultomiris, the pharma regulator’s website showed on Friday. The drug aims to treat paroxysmal…
(Reuters Health) – – More than two in five teens who use marijuana experience psychotic symptoms like hallucinations, paranoia and anxiety, a U.S. study suggests. FILE PHOTO: People roll a…
(Reuters) – An advisory panel to the U.S. Food and Drug Administration on Tuesday recommended prescribing the opioid overdose reversal drug, naloxone, along with addictive painkillers. FILE PHOTO: The drug…
NEW YORK (Reuters) – Johnson & Johnson on Monday scrambled to contain fallout from a Reuters report that the healthcare conglomerate knew for decades that cancer-causing asbestos lurked in its…
(Reuters Health) – – Researchers said last year that the proportion of overweight U.S. adults trying to lose weight has been shrinking – but newly reanalyzed data suggest the proportion…
(Reuters Health) – – While most parents heading out for alcohol-infused holiday parties will have arranged for child care while they’re out and for transportation back home in case they…
(Reuters) – Shares of Evofem Biosciences Inc jumped as much as 38 percent on Monday after its birth control gel showed effectiveness in a late-stage study, bringing the first hormone-free…
LOS ANGELES (Reuters) – Johnson & Johnson developed a strategy in the 1970s to deal with a growing volume of research showing that talc miners had elevated rates of lung…
(Reuters Health) – – People with inflammatory bowel diseases like Crohn’s disease and ulcerative colitis may be up to 12 times more likely to have a heart attack, a U.S.…
(Reuters) – A former physician assistant is set to face trial in New Hampshire on Wednesday over charges he accepted kickbacks from Insys Therapeutics Inc to prescribe a highly addictive…